ThinkstockFollowing a special shareholder meeting in St. Louis, Centene Corporation (NYSE: CNC) announced that its shareholders voted overwhelmingly to approve the issuance of Centene common stock to shareholders of Health Net, Inc. (NYSE: HNT)…
Amgen is slowly getting closer to an FDA final decision for its first-of-a-kind cancer therapy, talimogene laherparepvec (T-Vec).
On Thursday when a generic drug company based in San Diego said it will produce an alternative to the $750 per pill Daraprim.
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying advanced liver disease. The markets reacted…
Merrimack Pharmaceuticals saw its shares halted for "news pending" due to an approval from the FDA.
ThinkstockCommunity Health Systems Inc. (NYSE: CYH) is showing that the weakness in hospital and medical care facilities may not be over. Its preliminary financial and operating guidance has bushwhacked its shares on Thursday. Net…
Envision Healthcare was leading the bears in Thursday’s trading session after reporting its third-quarter earnings
Viventia Bio has filedwith the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Eli Lilly reported mixed third-quarter financial results on Thursday before the markets opened.
ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While the first half of…
If the federal government eventually makes pot use legal across the country, the decision will not come without substantial medical risks.
ThinkstockNeogenomics Inc. (NASDAQ: NEO) is leading the bulls in Wednesday’s trading session on news of an acquisition. The company announced that it has reached an agreement to acquire Clarient and its wholly-owned subsidiary Clarient…
Eli Lilly is scheduled to report its third-quarter earnings before the markets open on Thursday.
Biogen reported better-than-expected third-quarter financial results Wednesday before the market opened.